Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study

PURPOSE: The objective of this study was to assess the safety and tolerability of preservative-free bilastine 0.6% ophthalmic solution after 8 weeks of once-daily administration in patients with allergic conjunctivitis (AC). PATIENTS AND METHODS: Multi-center, international, randomized, double blind...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuna, Piotr, Jutel, Marek, Pulka, Grazyna, Tokarski, Slawomir, Arranz, Paula, Hernández, Gonzalo, Fernández Hernando, Nieves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994667/
https://www.ncbi.nlm.nih.gov/pubmed/36909350
http://dx.doi.org/10.2147/OPTH.S398168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994667/
https://www.ncbi.nlm.nih.gov/pubmed/36909350
http://dx.doi.org/10.2147/OPTH.S398168

Ejemplares similares